Difference between revisions of "Wednesday December 10, 2014"

From Ciswikidb
Jump to navigation Jump to search
 
Line 24: Line 24:
 
# Bubble chamber at JLab in early March 2015
 
# Bubble chamber at JLab in early March 2015
  
* There is interest in studying <sup>71</sup>Ga(γ,α)<sup>67</sup>Cu reaction in activation experiment (E<sub>Th</sub> = 5.2 MeV). <sup>67</sup>Cu has shown exceptional potential in the treatment of non-Hodgkin’s Lymphoma as well as bladder, colorectal, and ovarian cancers.
+
* There is interest in studying <sup>71</sup>Ga(γ,α)<sup>67</sup>Cu reaction in activation experiment (E<sub>Th</sub> = 5.2 MeV). Copper-67 has shown exceptional potential in the treatment of non-Hodgkin’s Lymphoma as well as bladder, colorectal, and ovarian cancers.

Latest revision as of 16:50, 9 January 2015

We will meet in TL 2221 on Wednesday December 10 at 3:30 pm EST.

For those calling in we'll use the Blue Jeans [1] audio conference system.

Phone number: 1-888-240-2560
Meeting ID: 3528502673#
Meeting URL: http://bluejeans.com/3528502673


Agenda:

1- Bubble Chamber progress at Argonne




Notes from this meeting:

  • Bubble Chamber:
  1. Parts leak-checked, chamber dis-assembled, ready to install new glass cell
  2. Plan to start testing new chamber in January 2015
  3. JLab bubble chamber safety review is now to be scheduled in early February 2015
  4. Bubble chamber at JLab in early March 2015
  • There is interest in studying 71Ga(γ,α)67Cu reaction in activation experiment (ETh = 5.2 MeV). Copper-67 has shown exceptional potential in the treatment of non-Hodgkin’s Lymphoma as well as bladder, colorectal, and ovarian cancers.